nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Porphyria cutanea tarda—Estradiol—osteoporosis	0.0591	0.0591	CcSEcCtD
Tolazamide—Porphyria non-acute—Estradiol—osteoporosis	0.0554	0.0554	CcSEcCtD
Tolazamide—Reaction gastrointestinal—Zoledronate—osteoporosis	0.0333	0.0333	CcSEcCtD
Tolazamide—Heartburn—Alendronate—osteoporosis	0.0232	0.0232	CcSEcCtD
Tolazamide—Jaundice cholestatic—Estropipate—osteoporosis	0.0184	0.0184	CcSEcCtD
Tolazamide—Eruption—Estradiol—osteoporosis	0.0139	0.0139	CcSEcCtD
Tolazamide—Jaundice cholestatic—Conjugated Estrogens—osteoporosis	0.0122	0.0122	CcSEcCtD
Tolazamide—Pancytopenia—Etidronic acid—osteoporosis	0.0112	0.0112	CcSEcCtD
Tolazamide—Abdominal distension—Estropipate—osteoporosis	0.0102	0.0102	CcSEcCtD
Tolazamide—Abdominal distension—Alendronate—osteoporosis	0.0101	0.0101	CcSEcCtD
Tolazamide—Agranulocytosis—Etidronic acid—osteoporosis	0.00978	0.00978	CcSEcCtD
Tolazamide—Jaundice cholestatic—Estradiol—osteoporosis	0.00975	0.00975	CcSEcCtD
Tolazamide—Photosensitivity reaction—Alendronate—osteoporosis	0.00914	0.00914	CcSEcCtD
Tolazamide—Feeling abnormal—Calcium Acetate—osteoporosis	0.00839	0.00839	CcSEcCtD
Tolazamide—Abdominal distension—Ethinyl Estradiol—osteoporosis	0.0083	0.0083	CcSEcCtD
Tolazamide—Erythema—Etidronic acid—osteoporosis	0.00819	0.00819	CcSEcCtD
Tolazamide—Abdominal distension—Risedronate—osteoporosis	0.00809	0.00809	CcSEcCtD
Tolazamide—Leukopenia—Etidronic acid—osteoporosis	0.00733	0.00733	CcSEcCtD
Tolazamide—Asthenia—Calcium Acetate—osteoporosis	0.00731	0.00731	CcSEcCtD
Tolazamide—Pruritus—Calcium Acetate—osteoporosis	0.0072	0.0072	CcSEcCtD
Tolazamide—Erythema—Estropipate—osteoporosis	0.00709	0.00709	CcSEcCtD
Tolazamide—Abdominal distension—Zoledronate—osteoporosis	0.00702	0.00702	CcSEcCtD
Tolazamide—Erythema—Alendronate—osteoporosis	0.00698	0.00698	CcSEcCtD
Tolazamide—Discomfort—Etidronic acid—osteoporosis	0.00689	0.00689	CcSEcCtD
Tolazamide—Erythema—Ibandronate—osteoporosis	0.00679	0.00679	CcSEcCtD
Tolazamide—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00676	0.00676	CcSEcCtD
Tolazamide—Dizziness—Calcium Acetate—osteoporosis	0.00673	0.00673	CcSEcCtD
Tolazamide—Erythema—Calcitriol—osteoporosis	0.00665	0.00665	CcSEcCtD
Tolazamide—Pancytopenia—Zoledronate—osteoporosis	0.00663	0.00663	CcSEcCtD
Tolazamide—Ill-defined disorder—Alendronate—osteoporosis	0.00648	0.00648	CcSEcCtD
Tolazamide—Asthenia—Ergocalciferol—osteoporosis	0.00645	0.00645	CcSEcCtD
Tolazamide—Vertigo—Estropipate—osteoporosis	0.00637	0.00637	CcSEcCtD
Tolazamide—Agranulocytosis—Pamidronate—osteoporosis	0.00636	0.00636	CcSEcCtD
Tolazamide—Ill-defined disorder—Ibandronate—osteoporosis	0.0063	0.0063	CcSEcCtD
Tolazamide—Malaise—Alendronate—osteoporosis	0.00629	0.00629	CcSEcCtD
Tolazamide—Vertigo—Alendronate—osteoporosis	0.00627	0.00627	CcSEcCtD
Tolazamide—Vertigo—Raloxifene—osteoporosis	0.00617	0.00617	CcSEcCtD
Tolazamide—Malaise—Ibandronate—osteoporosis	0.00613	0.00613	CcSEcCtD
Tolazamide—Vertigo—Ibandronate—osteoporosis	0.0061	0.0061	CcSEcCtD
Tolazamide—Nausea—Calcium Acetate—osteoporosis	0.00605	0.00605	CcSEcCtD
Tolazamide—Dyspepsia—Etidronic acid—osteoporosis	0.00588	0.00588	CcSEcCtD
Tolazamide—Discomfort—Alendronate—osteoporosis	0.00587	0.00587	CcSEcCtD
Tolazamide—Agranulocytosis—Zoledronate—osteoporosis	0.00581	0.00581	CcSEcCtD
Tolazamide—Discomfort—Ibandronate—osteoporosis	0.00572	0.00572	CcSEcCtD
Tolazamide—Discomfort—Calcitriol—osteoporosis	0.00559	0.00559	CcSEcCtD
Tolazamide—Feeling abnormal—Etidronic acid—osteoporosis	0.00551	0.00551	CcSEcCtD
Tolazamide—Thrombocytopenia—Raloxifene—osteoporosis	0.00548	0.00548	CcSEcCtD
Tolazamide—Abdominal distension—Estradiol—osteoporosis	0.00541	0.00541	CcSEcCtD
Tolazamide—Nausea—Ergocalciferol—osteoporosis	0.00534	0.00534	CcSEcCtD
Tolazamide—Ill-defined disorder—Ethinyl Estradiol—osteoporosis	0.00533	0.00533	CcSEcCtD
Tolazamide—Erythema—Pamidronate—osteoporosis	0.00532	0.00532	CcSEcCtD
Tolazamide—Urticaria—Etidronic acid—osteoporosis	0.00531	0.00531	CcSEcCtD
Tolazamide—Malaise—Ethinyl Estradiol—osteoporosis	0.00518	0.00518	CcSEcCtD
Tolazamide—Dyspepsia—Estropipate—osteoporosis	0.00509	0.00509	CcSEcCtD
Tolazamide—Vertigo—Risedronate—osteoporosis	0.00503	0.00503	CcSEcCtD
Tolazamide—Dyspepsia—Alendronate—osteoporosis	0.00501	0.00501	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Estropipate—osteoporosis	0.00499	0.00499	CcSEcCtD
Tolazamide—Fatigue—Estropipate—osteoporosis	0.00499	0.00499	CcSEcCtD
Tolazamide—Ill-defined disorder—Pamidronate—osteoporosis	0.00494	0.00494	CcSEcCtD
Tolazamide—Dyspepsia—Raloxifene—osteoporosis	0.00493	0.00493	CcSEcCtD
Tolazamide—Photosensitivity reaction—Estradiol—osteoporosis	0.00491	0.00491	CcSEcCtD
Tolazamide—Dyspepsia—Ibandronate—osteoporosis	0.00488	0.00488	CcSEcCtD
Tolazamide—Erythema—Zoledronate—osteoporosis	0.00486	0.00486	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00484	0.00484	CcSEcCtD
Tolazamide—Discomfort—Ethinyl Estradiol—osteoporosis	0.00483	0.00483	CcSEcCtD
Tolazamide—Malaise—Pamidronate—osteoporosis	0.0048	0.0048	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00479	0.00479	CcSEcCtD
Tolazamide—Fatigue—Ibandronate—osteoporosis	0.00478	0.00478	CcSEcCtD
Tolazamide—Leukopenia—Pamidronate—osteoporosis	0.00476	0.00476	CcSEcCtD
Tolazamide—Pruritus—Etidronic acid—osteoporosis	0.00473	0.00473	CcSEcCtD
Tolazamide—Feeling abnormal—Alendronate—osteoporosis	0.00469	0.00469	CcSEcCtD
Tolazamide—Erythema—Conjugated Estrogens—osteoporosis	0.00468	0.00468	CcSEcCtD
Tolazamide—Urticaria—Estropipate—osteoporosis	0.00459	0.00459	CcSEcCtD
Tolazamide—Feeling abnormal—Ibandronate—osteoporosis	0.00457	0.00457	CcSEcCtD
Tolazamide—Urticaria—Alendronate—osteoporosis	0.00452	0.00452	CcSEcCtD
Tolazamide—Ill-defined disorder—Zoledronate—osteoporosis	0.00451	0.00451	CcSEcCtD
Tolazamide—Discomfort—Pamidronate—osteoporosis	0.00448	0.00448	CcSEcCtD
Tolazamide—Urticaria—Ibandronate—osteoporosis	0.00441	0.00441	CcSEcCtD
Tolazamide—Malaise—Zoledronate—osteoporosis	0.00438	0.00438	CcSEcCtD
Tolazamide—Vertigo—Zoledronate—osteoporosis	0.00437	0.00437	CcSEcCtD
Tolazamide—Leukopenia—Zoledronate—osteoporosis	0.00435	0.00435	CcSEcCtD
Tolazamide—Urticaria—Calcitriol—osteoporosis	0.00431	0.00431	CcSEcCtD
Tolazamide—Thrombocytopenia—Pamidronate—osteoporosis	0.00425	0.00425	CcSEcCtD
Tolazamide—Rash—Etidronic acid—osteoporosis	0.00421	0.00421	CcSEcCtD
Tolazamide—Vertigo—Conjugated Estrogens—osteoporosis	0.00421	0.00421	CcSEcCtD
Tolazamide—Headache—Etidronic acid—osteoporosis	0.00419	0.00419	CcSEcCtD
Tolazamide—Asthenia—Estropipate—osteoporosis	0.00415	0.00415	CcSEcCtD
Tolazamide—Pruritus—Estropipate—osteoporosis	0.00409	0.00409	CcSEcCtD
Tolazamide—Discomfort—Zoledronate—osteoporosis	0.00409	0.00409	CcSEcCtD
Tolazamide—Asthenia—Alendronate—osteoporosis	0.00409	0.00409	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00405	0.00405	CcSEcCtD
Tolazamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.00404	0.00404	CcSEcCtD
Tolazamide—Pruritus—Alendronate—osteoporosis	0.00403	0.00403	CcSEcCtD
Tolazamide—Dyspepsia—Risedronate—osteoporosis	0.00402	0.00402	CcSEcCtD
Tolazamide—Asthenia—Ibandronate—osteoporosis	0.00398	0.00398	CcSEcCtD
Tolazamide—Nausea—Etidronic acid—osteoporosis	0.00397	0.00397	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Risedronate—osteoporosis	0.00395	0.00395	CcSEcCtD
Tolazamide—Fatigue—Risedronate—osteoporosis	0.00394	0.00394	CcSEcCtD
Tolazamide—Pruritus—Ibandronate—osteoporosis	0.00392	0.00392	CcSEcCtD
Tolazamide—Asthenia—Calcitriol—osteoporosis	0.00389	0.00389	CcSEcCtD
Tolazamide—Thrombocytopenia—Zoledronate—osteoporosis	0.00389	0.00389	CcSEcCtD
Tolazamide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00386	0.00386	CcSEcCtD
Tolazamide—Pruritus—Calcitriol—osteoporosis	0.00384	0.00384	CcSEcCtD
Tolazamide—Dyspepsia—Pamidronate—osteoporosis	0.00382	0.00382	CcSEcCtD
Tolazamide—Dizziness—Estropipate—osteoporosis	0.00382	0.00382	CcSEcCtD
Tolazamide—Dizziness—Alendronate—osteoporosis	0.00377	0.00377	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00375	0.00375	CcSEcCtD
Tolazamide—Erythema—Estradiol—osteoporosis	0.00375	0.00375	CcSEcCtD
Tolazamide—Fatigue—Pamidronate—osteoporosis	0.00375	0.00375	CcSEcCtD
Tolazamide—Urticaria—Ethinyl Estradiol—osteoporosis	0.00372	0.00372	CcSEcCtD
Tolazamide—Dizziness—Raloxifene—osteoporosis	0.0037	0.0037	CcSEcCtD
Tolazamide—Dizziness—Ibandronate—osteoporosis	0.00367	0.00367	CcSEcCtD
Tolazamide—Rash—Estropipate—osteoporosis	0.00365	0.00365	CcSEcCtD
Tolazamide—Urticaria—Risedronate—osteoporosis	0.00363	0.00363	CcSEcCtD
Tolazamide—Headache—Estropipate—osteoporosis	0.00362	0.00362	CcSEcCtD
Tolazamide—Rash—Alendronate—osteoporosis	0.00359	0.00359	CcSEcCtD
Tolazamide—Feeling abnormal—Pamidronate—osteoporosis	0.00358	0.00358	CcSEcCtD
Tolazamide—Headache—Alendronate—osteoporosis	0.00357	0.00357	CcSEcCtD
Tolazamide—Rash—Raloxifene—osteoporosis	0.00353	0.00353	CcSEcCtD
Tolazamide—Headache—Raloxifene—osteoporosis	0.00351	0.00351	CcSEcCtD
Tolazamide—Rash—Ibandronate—osteoporosis	0.0035	0.0035	CcSEcCtD
Tolazamide—Dyspepsia—Zoledronate—osteoporosis	0.00349	0.00349	CcSEcCtD
Tolazamide—Ill-defined disorder—Estradiol—osteoporosis	0.00348	0.00348	CcSEcCtD
Tolazamide—Headache—Ibandronate—osteoporosis	0.00347	0.00347	CcSEcCtD
Tolazamide—Nausea—Estropipate—osteoporosis	0.00343	0.00343	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00343	0.00343	CcSEcCtD
Tolazamide—Rash—Calcitriol—osteoporosis	0.00342	0.00342	CcSEcCtD
Tolazamide—Fatigue—Zoledronate—osteoporosis	0.00342	0.00342	CcSEcCtD
Tolazamide—Headache—Calcitriol—osteoporosis	0.0034	0.0034	CcSEcCtD
Tolazamide—Nausea—Alendronate—osteoporosis	0.00338	0.00338	CcSEcCtD
Tolazamide—Malaise—Estradiol—osteoporosis	0.00338	0.00338	CcSEcCtD
Tolazamide—Vertigo—Estradiol—osteoporosis	0.00337	0.00337	CcSEcCtD
Tolazamide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00336	0.00336	CcSEcCtD
Tolazamide—Asthenia—Ethinyl Estradiol—osteoporosis	0.00336	0.00336	CcSEcCtD
Tolazamide—Nausea—Raloxifene—osteoporosis	0.00333	0.00333	CcSEcCtD
Tolazamide—Pruritus—Ethinyl Estradiol—osteoporosis	0.00332	0.00332	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.0033	0.0033	CcSEcCtD
Tolazamide—Fatigue—Conjugated Estrogens—osteoporosis	0.00329	0.00329	CcSEcCtD
Tolazamide—Nausea—Ibandronate—osteoporosis	0.00329	0.00329	CcSEcCtD
Tolazamide—Asthenia—Risedronate—osteoporosis	0.00328	0.00328	CcSEcCtD
Tolazamide—Feeling abnormal—Zoledronate—osteoporosis	0.00327	0.00327	CcSEcCtD
Tolazamide—Pruritus—Risedronate—osteoporosis	0.00323	0.00323	CcSEcCtD
Tolazamide—Nausea—Calcitriol—osteoporosis	0.00322	0.00322	CcSEcCtD
Tolazamide—Urticaria—Zoledronate—osteoporosis	0.00315	0.00315	CcSEcCtD
Tolazamide—Discomfort—Estradiol—osteoporosis	0.00315	0.00315	CcSEcCtD
Tolazamide—Asthenia—Pamidronate—osteoporosis	0.00312	0.00312	CcSEcCtD
Tolazamide—Dizziness—Ethinyl Estradiol—osteoporosis	0.0031	0.0031	CcSEcCtD
Tolazamide—Pruritus—Pamidronate—osteoporosis	0.00307	0.00307	CcSEcCtD
Tolazamide—Urticaria—Conjugated Estrogens—osteoporosis	0.00304	0.00304	CcSEcCtD
Tolazamide—Dizziness—Risedronate—osteoporosis	0.00302	0.00302	CcSEcCtD
Tolazamide—Rash—Ethinyl Estradiol—osteoporosis	0.00296	0.00296	CcSEcCtD
Tolazamide—Headache—Ethinyl Estradiol—osteoporosis	0.00294	0.00294	CcSEcCtD
Tolazamide—Rash—Risedronate—osteoporosis	0.00288	0.00288	CcSEcCtD
Tolazamide—Dizziness—Pamidronate—osteoporosis	0.00287	0.00287	CcSEcCtD
Tolazamide—Headache—Risedronate—osteoporosis	0.00286	0.00286	CcSEcCtD
Tolazamide—Asthenia—Zoledronate—osteoporosis	0.00285	0.00285	CcSEcCtD
Tolazamide—Pruritus—Zoledronate—osteoporosis	0.00281	0.00281	CcSEcCtD
Tolazamide—Nausea—Ethinyl Estradiol—osteoporosis	0.00278	0.00278	CcSEcCtD
Tolazamide—Asthenia—Conjugated Estrogens—osteoporosis	0.00274	0.00274	CcSEcCtD
Tolazamide—Rash—Pamidronate—osteoporosis	0.00274	0.00274	CcSEcCtD
Tolazamide—Headache—Pamidronate—osteoporosis	0.00272	0.00272	CcSEcCtD
Tolazamide—Nausea—Risedronate—osteoporosis	0.00271	0.00271	CcSEcCtD
Tolazamide—Pruritus—Conjugated Estrogens—osteoporosis	0.0027	0.0027	CcSEcCtD
Tolazamide—Dyspepsia—Estradiol—osteoporosis	0.00269	0.00269	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Estradiol—osteoporosis	0.00264	0.00264	CcSEcCtD
Tolazamide—Fatigue—Estradiol—osteoporosis	0.00264	0.00264	CcSEcCtD
Tolazamide—Dizziness—Zoledronate—osteoporosis	0.00262	0.00262	CcSEcCtD
Tolazamide—Nausea—Pamidronate—osteoporosis	0.00258	0.00258	CcSEcCtD
Tolazamide—Dizziness—Conjugated Estrogens—osteoporosis	0.00253	0.00253	CcSEcCtD
Tolazamide—Feeling abnormal—Estradiol—osteoporosis	0.00252	0.00252	CcSEcCtD
Tolazamide—Rash—Zoledronate—osteoporosis	0.0025	0.0025	CcSEcCtD
Tolazamide—Headache—Zoledronate—osteoporosis	0.00249	0.00249	CcSEcCtD
Tolazamide—Urticaria—Estradiol—osteoporosis	0.00243	0.00243	CcSEcCtD
Tolazamide—Rash—Conjugated Estrogens—osteoporosis	0.00241	0.00241	CcSEcCtD
Tolazamide—Headache—Conjugated Estrogens—osteoporosis	0.00239	0.00239	CcSEcCtD
Tolazamide—Nausea—Zoledronate—osteoporosis	0.00236	0.00236	CcSEcCtD
Tolazamide—Nausea—Conjugated Estrogens—osteoporosis	0.00227	0.00227	CcSEcCtD
Tolazamide—Asthenia—Estradiol—osteoporosis	0.00219	0.00219	CcSEcCtD
Tolazamide—Pruritus—Estradiol—osteoporosis	0.00216	0.00216	CcSEcCtD
Tolazamide—Dizziness—Estradiol—osteoporosis	0.00202	0.00202	CcSEcCtD
Tolazamide—Rash—Estradiol—osteoporosis	0.00193	0.00193	CcSEcCtD
Tolazamide—Headache—Estradiol—osteoporosis	0.00192	0.00192	CcSEcCtD
Tolazamide—Nausea—Estradiol—osteoporosis	0.00182	0.00182	CcSEcCtD
